07:00 , Jun 29, 2009 |  BC Week In Review  |  Clinical News

Biovista preclinical data

In a mouse model of epilepsy, BVA-601 significantly decreased epileptic activity and delayed the onset of epileptic seizures compared with diazepam (p<0.05 for both). BVA-601 is an undisclosed drug that Biovista is repositioning for epilepsy....